Literature DB >> 7852186

Rearrangement of bcl-2 is detectable in Hodgkin's disease by polymerase chain reaction.

S Mitani1, T Oka, N Aoki, I Hojo, U Ota, S Mori.   

Abstract

The authors examined the occurrence of the t(14;18) chromosomal translocation in 44 cases of Hodgkin's disease (HD) using the polymerase chain reaction and Southern blot hybridization with non-radioactive oligonucleotide probes. DNAs were extracted from unfixed, fresh-frozen and formalin-fixed, paraffin-embedded biopsy specimens. Southern blot hybridization of the amplification product showed that, of 44 HD DNAs, three had a detectable t(14;18) breakpoint at the mbr (major breakpoint region), while none had a detectable t(14;18) breakpoint at the mcr (minor cluster region). Of the three cases positive for a t(14;18) breakpoint at the mbr, two were of lymphocyte predominance type, and the other was of mixed cellularity type.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7852186      PMCID: PMC5919386          DOI: 10.1111/j.1349-7006.1994.tb02934.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  34 in total

1.  Direct sequence analysis of the t(14;18) chromosomal translocation in Hodgkin's disease.

Authors:  R K Gupta; J S Whelan; T A Lister; B D Young; J G Bodmer
Journal:  Blood       Date:  1992-04-15       Impact factor: 22.113

2.  Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.

Authors:  G Nuñez; L London; D Hockenbery; M Alexander; J P McKearn; S J Korsmeyer
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

3.  The bcl-2 gene, follicular lymphoma, and Hodgkin's disease.

Authors:  M Cleary; S A Rosenberg
Journal:  J Natl Cancer Inst       Date:  1990-05-16       Impact factor: 13.506

4.  Chromosomal abnormalities in Hodgkin's disease.

Authors:  H C Schouten; W G Sanger; M Duggan; D D Weisenburger; K A MacLennan; J O Armitage
Journal:  Blood       Date:  1989-06       Impact factor: 22.113

5.  Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyte.

Authors:  F Cabanillas; S Pathak; J Trujillo; G Grant; A Cork; F B Hagemeister; W S Velasquez; P McLaughlin; J Redman; R Katz
Journal:  Blood       Date:  1988-06       Impact factor: 22.113

6.  Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase.

Authors:  G G Schmitz; T Walter; R Seibl; C Kessler
Journal:  Anal Biochem       Date:  1991-01       Impact factor: 3.365

7.  Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer.

Authors:  J J Yunis; G Frizzera; M M Oken; J McKenna; A Theologides; M Arnesen
Journal:  N Engl J Med       Date:  1987-01-08       Impact factor: 91.245

8.  There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin's lymphomas.

Authors:  E G Levine; D C Arthur; G Frizzera; B A Peterson; D D Hurd; C D Bloomfield
Journal:  Blood       Date:  1985-12       Impact factor: 22.113

9.  Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease.

Authors:  M Crescenzi; M Seto; G P Herzig; P D Weiss; R C Griffith; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

10.  bcl-2 gene rearrangement analysis of Japanese follicular lymphomas by polymerase chain reaction in formalin-fixed, paraffin-embedded tissue specimens.

Authors:  S Mitani; N Aoki; S Mizutani; M Fujiwara; T Kitagawa; T Uehara; S Mori
Journal:  Jpn J Cancer Res       Date:  1993-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.